Apr 07
FDA approves Horizant to treat restless legs syndrome
Posted by (author unknown) on Thursday Apr 7, 2011 Under UncategorizedOn April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS).
RSS Reader Subscription